| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 20610 |
|
5,911 |
3,134 |
$176K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,664 |
5,278 |
$162K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
661 |
265 |
$117K |
| 99215 |
Prolong outpt/office vis |
1,588 |
1,538 |
$72K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
373 |
176 |
$64K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,006 |
1,592 |
$27K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,788 |
1,614 |
$12K |
| 94760 |
|
4,106 |
3,686 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
617 |
385 |
$5K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
2,049 |
1,076 |
$4K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,698 |
701 |
$2K |
| 99245 |
|
15 |
15 |
$735.84 |
| 95115 |
|
1,708 |
703 |
$527.88 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
48 |
31 |
$75.32 |
| J7331 |
Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg |
19 |
14 |
$70.72 |
| 4192F |
|
994 |
926 |
$0.00 |
| 3476F |
|
775 |
719 |
$0.00 |
| 3455F |
|
688 |
640 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
195 |
173 |
$0.00 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$0.00 |
| 3470F |
|
13 |
13 |
$0.00 |
| 4195F |
|
775 |
720 |
$0.00 |
| M1003 |
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy |
953 |
893 |
$0.00 |
| 1006F |
|
642 |
594 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
362 |
325 |
$0.00 |
| M1007 |
>=50% of total number of a patient's outpatient ra encounters assessed |
994 |
927 |
$0.00 |
| 1170F |
|
995 |
927 |
$0.00 |